Corporate report
CA98 register of directions and commitments currently in force
Updated 22 April 2026
Directions
| Case name | Summary | Case number | Direction given on | Direction |
|---|---|---|---|---|
| Genzyme Limited | Abuse of dominance by Genzyme Limited in relation to their supply of the drug Cerezyme (treatment of Gaucher disease). Infringement decision in respect of Chapter II CA98. |
CA98/3/03 | 27 Mar 2003 | Direction by the CAT on 29 September 2005 (PDF, 34KB) |
| Napp Pharmaceutical Holdings Ltd: alleged abuse of a dominant position | Abuse of dominant position: alleged anti-competitive pricing practices by Napp concerning the supply of morphine. Infringement decision in respect of Chapter II CA98. On 15 January 2002 the CAT substantially upheld the OFT’s decision on liability. Directions confirmed, however see paragraph 558 of the CAT Judgement (PDF, 645KB) with respect to paragraph 2(d) of the directions where the CAT advised the OFT to keep this aspect under review. |
CA98/2D/2001 | 5 Apr 2001 | Detail of direction (PDF, 27KB) |
| Phenytoin sodium capsules: suspected unfair pricing | The CMA investigated alleged excessive and unfair prices for phenytoin sodium capsules under Chapter II of CA98 and Article 102 TFEU. | CE/9742-13 | 15 June 2017 | Directions in the CMA’s decision (PDF, 319MB) on 15.06.2017 |
| Sports equipment sector: anti-competitive practices (Ping) | The CMA investigated a suspected breach of competition law in the sports equipment sector under Chapter I of CA98 and Article 101 of TFEU. | 50230 | 21 Dec 2017 | Directions in the CMA’s decision (PDF, 3.87MB) on 21.12.2017 |
Sector regulators
| Case name | Sector regulator | Summary | Directions given on | Directions |
|---|---|---|---|---|
| Investigation into National Grid | Ofgem | Infringement decision in respect of Chapter II CA98 and Article 102 TFEU | 21 Feb 2008 | Details of direction (PDF, 104MB) |
Commitments
| Case name | Authority | Case number | Type of conduct investigated | Commitment accepted on | Summary of commitments |
|---|---|---|---|---|---|
| Investigation into suspected anti-competitive conduct by housebuilders | CMA | AT-51392 | Anti-competitive agreement | 30 October 2025 | Agree not to share certain types of information with other housebuilders, including the prices houses have been sold for, except in limited circumstances. Introduce enhanced compliance measures and training programmes. Work with the Home Builders Federation and Homes for Scotland to develop industry-wide guidance on information sharing. Make a combined £100 million payment which will be split between affordable housing programmes across all 4 nations of the United Kingdom. |
| Investigation into the Atlantic Joint Business Agreement between American Airlines, members of International Consolidated Airlines Group (British Airways, Iberia and Aer Lingus) and Finnair under Chapter I of the CA98 | CMA | Anti-competitive agreement | 7 August 2025 | Give competitor airlines slots for take-off and landing at London airports on the London-Boston, London-Miami, and London-Chicago routes. Carry a minimum number of ‘local passengers’ on the London-Dallas route each year. Support competing airlines on the Boston, Chicago and Miami routes through other measures, including giving access to connecting passengers on preferential terms. | |
| Investigation into suspected anti-competitive conduct by Vifor Pharma in relation to intravenous iron treatments | CMA | AT-51377 | Abuse of dominance | 23 May 2025 | Make a voluntary payment of £23 million to the NHS. Correct any potentially misleading communications disseminated by Vifor Pharma regarding the safety of Monofer and Ferinject, via a multi-channel communications campaign to healthcare professionals. Introduce several compliance measures to prevent the future dissemination of potentially misleading communications regarding the safety of Monofer and Ferinject to healthcare professionals. |
| Investigation into Meta’s (formerly Facebook) use of data | CMA | AT 51013 | Abuse of dominance | 3 November 2023 (and varied after 20 August 2024) | Allowing competitors advertising on Meta platforms to opt out of certain ad data being used by Meta in Facebook Marketplace. Limiting the way Meta uses certain ad data in product development in the UK. |
| Investigation into Amazon’s Marketplace | CMA | 51184 | Abuse of dominance | 3 November 2023 | Ensure Amazon does not use rival sellers’ Marketplace data to gain an unfair advantage over other sellers. Guarantee all product offers are treated equally when Amazon decides which will be featured in the ‘Buy Box’. Allow third-party businesses using Marketplace to negotiate their own rates directly with independent providers of Prime delivery services. Require Amazon to appoint an independent trustee who will monitor the company’s compliance with these commitments. |
| Investigation into conduct of Education Software Solutions Limited | CMA | 51140 | Abuse of dominance | 10 January 2023 | - Enables certain schools to apply to an independent adjudicator for a 12-month break clause |
| Investigation into a capacity sharing agreement between P&O Ferries and DFDS | CMA | 51099 | Chapter 1 CA98 Anti-competitive agreement | 5 August 2022 | Not agree with one another the number of sailings that each company operates. Put strict limits on the number of sailings that they may cancel. Amend the agreement to make clear that it does not fix the amount of freight customers that either company may carry. |
| Investigation into the supply of electric vehicle chargepoints on or near motorways | CMA | 51050 | Abuse of dominance | 8 March 2022 | Not to enforce exclusive rights in contracts with Extra, MOTO or Roadchef, after November 2026. Not to enforce exclusive rights at any Extra, MOTO or Roadchef sites that are granted funding under the UK government’s Rapid Charging Fund (RCF). |
| Investigation into supply of lithium-based medication for the treatment of bipolar disease | CMA | 50951 | Abuse of dominance | 18 Dec 2020 | Continue to supply Priadel on terms agreed with the DHSC for 5 years. |
| Fludrocortisone acetate tablets: anti-competitive agreement | CMA | 50455 | anti-competitive agreement | 3 October 2019 | Ensuring that, in future, there will be at least 2 suppliers of fludrocortisone in the UK. |
| Showmen’s Guild: suspected anti-competitive practices | CMA | 50243 | Chapter 1 CA98 Anti-competitive agreement |
26 October 2017 | The CMA has accepted commitments from the Showmen’s Guild of Great Britain that address the CMA’s competition concerns. The Guild changed rules applied to Guild members. CMA’s decision to accept commitments (PDF,478KB) |
Sector regulators
| Case name | Sector regulator | Type of conduct investigated | Commitment accepted in | Summary of commitments |
|---|---|---|---|---|
| Investigation into Scotia Gas Networks Group in relation to gas transportation or activities ancillary to gas transportation | Ofgem | Chapter II CA98: abuse of dominance | 2 December 2025 | Maintain a published SLO-1 audit framework. Review and update the SLO-1 audit framework. Maintain a 4B Statement that publicises the existence of the SLO-1. |
| Investigation under section 25 of the Competition Act 1998 in respect of the rules for membership of the RACF (PDF, 529KB) | ORR | Anti-competitive agreement | April 2022 | Adopt the Rules in the form agreed; notify ORR of any changes made to the Rules and/or the policies referred to within the Rules for a period of 5 years; make the Rules of membership publicly available on RACF’s website within 28 days of being first implemented by RACF and keep an up-to-date version of the Rules on RACF’s website; and retain information on membership applications and decisions for a period of 3 years following each, and provide such information to ORR on reasonable request; to include on RACF’s website an explanatory explaining what the Rules are intended to achieve. |
| Paypoint plc (PDF, 860KB) | Ofgem | Abuse of dominance | November 2021 | Removal of exclusivity provisions concerning energy pre-payment services from current contracts and any future contracts entered into during the next five years with energy suppliers and retailers. Offering separate contracts to energy suppliers for the provision of OTC and non-OTC energy prepayment services. Donation of £12.5 million to Ofgem’s Energy Industry Voluntary Redress Scheme (currently administered on Ofgem’s behalf by the Energy Saving Trust). |
| EPEX Spot SE and EEX | Ofgem | Abuse of Dominance | June 2019 | to take steps required of EPEX to enable other Nominated Electricity Market Operators, in particular Nord Pool, to participate in certain electricity trading auctions between Great Britain and Ireland; and also to carry out an internal review of its competition law training. |
| Provision of Deep Sea Container rail transport services between ports and key inland destinations in Great Britain | ORR | Anti-competitive agreement and/or abuse of dominance | December 2015 | (1) No exclusivity contracts; (2) Contracts with duration up to 5 years and no rollover clause; (3) Restrictions on permitted rebates; (4) No reselling restrictions |
| Severn Trent (PDF, 217KB) | Ofwat | Abuse of dominance | January 2013 | Divestiture of downstream subsidiary |
| Electricity North West (PDF, 547KB) | Ofgem | Abuse of dominance | May 2012 | Undertaking the costs of boundary metering and refunding certain charges |